Recent News
Early December coverage noted a stepped-up hiring and pay program in London alongside broader headcount growth for the firm. The company presented at a December financial services conference, and reporting since November included an analyst group raising earnings estimates and at least one institutional investor trimming its stake.
Technical Analysis
Directional indicators show a bearish bias: ADX at 26.48 indicates a strong trend in place, DI- at 27.82 rising while DI+ at 15.41 declines, which favors downside pressure and elevates the probability that sellers remain in control.
Momentum measures confirm weakening price action: MACD stands negative at -2.65 and the MACD trend is decreasing with the signal at -0.01, indicating bearish momentum and no bullish MACD crossover at present.
Price sits below key averages and the cloud: the close at $162.50 trades under the 20-day average ($175.12), 50-day average ($173.90) and 200-day average ($169.37); the 12- and 26-day EMAs decline, and the Ichimoku components (Tenkan/Kijun around $175.53 and the cloud near $171.17–$171.49) place the stock beneath the cloud—technical structure that supports further downward bias.
Bollinger positioning sits near the lower band (lower 1× std dev $162.92; lower 2× $150.72) with current price just below the 1× lower band, implying limited immediate downside room inside the recent volatility envelope but persistent selling pressure. Volume at 382,001 above the 10-day average (357,130) shows active participation on recent moves, while 42-day beta (1.44) points to above-market short-term sensitivity.
MRO and RSI add toward a bearish near-term outlook: MRO at 0.66 (trend decreasing) indicates price sits marginally above target and therefore carries a tendency to pull back, while RSI at 48.54 with a decreasing trend shows neutral-to-weak momentum rather than oversold relief.
Fundamental Analysis
The company reported results with a date-ending of 2025-12-31 and a report date of February 3, 2026; the quarterly release and accompanying disclosures include capital actions and liquidity details. The firm held $586 million in cash, cash equivalents and short-term investments at year-end and continued share repurchases through the period.
EPS metrics: reported diluted EPS came in at $2.55 versus an estimate of $2.40, an EPS surprise of +6.25% (EPS beat of $0.15). Forward EPS stands at $2.17 with a forward P/E near 78.88. Current P/E reads 68.84 while PEG sits at 1.82; the PEG compares below the industry peer mean of 4.80, and the P/E sits slightly below the industry peer mean of 73.30, though forward P/E registers above the industry peer mean of 67.55—signals that near-term profitability outperformance coexists with elevated forward expectations.
Growth cadence shows divergence by period: reported earnings growth metrics translate to +37.84% on a point-in-time basis, with quarter-over-quarter earnings growth at +87.97% and year-over-year earnings growth at -63.72%. Reported revenue growth metrics show 0.0% with both QoQ and YoY figures at -100.00% per the provided measures. These moves reflect volatile period-to-period comparables and a pronounced QoQ improvement versus a difficult YoY base.
Balance-sheet and capital management notes include no funded debt and active buybacks—2.4 million shares repurchased over the year at an average price consistent with the mid-$150s—and a remaining repurchase authorization. WMDST values the stock as over-valued given the combination of elevated P/E and forward multiples relative to realized growth and the compressed analyst mean price target ($164.96) versus current price ($162.50).
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-02-03 |
| NEXT REPORT DATE: | 2026-05-05 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 2.40 | |
| EPS Actual | $ 2.55 | |
| EPS Difference | $ 0.15 | |
| EPS Surprise | 6.25 % | |
| Forward EPS | $ 2.17 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 68.836 | |
| Price To Earnings QoQ | -27.487 % | |
| Price To Earnings YoY | -16.133 % | |
| Price To Earnings IPRWA | high: 122.631 mean: 73.295 PJT: 68.836 median: 37.589 low: 15.501 |
|
| PE/G Ratio | 1.819 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 78.879 | |
| Forward PE/G | 2.085 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 0.0 | |
| Cash Conversion Cycle Days QoQ | -100.0 % | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ 12.8 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 3.379 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 0.0 % | |
| Revenue Growth QoQ | -100.0 % | |
| Revenue Growth YoY | -100.0 % | |
| Revenue Growth IPRWA | high: 20.638 % median: 1.415 % PJT: 0.0 % mean: -0.839 % low: -29.84 % |
|
| Earnings Growth | 37.838 % | |
| Earnings Growth QoQ | 87.968 % | |
| Earnings Growth YoY | -63.722 % | |
| Earnings Growth IPRWA | high: 45.455 % PJT: 37.838 % mean: -7.018 % median: -8.039 % low: -27.966 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | — | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |